Browse by Journal Title

Article

Small-molecule dual PLK1 and BRD4 inhibitors are active against preclinical models of pediatric solid tumors.
Timme, N. and Han, Y. and Liu, S. and Yosief, H.O. and García, H.D. and Bei, Y. and Klironomos, F. and MacArthur, I.C. and Szymansky, A. and von Stebut, J. and Bardinet, V. and Dohna, C. and Künkele, A. and Rolff, J. and Hundsdörfer, P. and Lissat, A. and Seifert, G. and Eggert, A. and Schulte, J.H. and Zhang, W. and Henssen, A.G.
Translational Oncology 13 (2): 221-232. February 2020

Genome-wide analysis of barrett's adenocarcinoma. a first step towards identifying patients at risk and developing therapeutic paths.
Dai, Y. and Wang, Q. and Gonzalez Lopez, A. and Anders, M. and Malfertheiner, P. and Vieth, M. and Kemmner, W.
Translational Oncology 11 (1): 116-124. February 2018

Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs.
Loeschmann, N. and Michaelis, M. and Rothweiler, F. and Zehner, R. and Cinatl, J. and Voges, Y. and Sharifi, M. and Riecken, K. and Meyer, J. and von Deimling, A. and Fichtner, I. and Ghafourian, T. and Westermann, F. and Cinatl Jr., J.
Translational Oncology 6 (6): 685-696. December 2013